AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23138384
Drug: Protocol A
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol A (imaging delay 4 s, 48 ml contrast medium)
Trial: 23138384
Drug: Protocol B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol B (imaging delay 8 s, 64 ml contrast medium)
Trial: 23138384
Drug: Protocol C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol C (imaging delay 12 s, 80 ml contrast medium)
Trial: 16650679
Drug: Ophthalmic care
RxNorm normalized name: atropine sulfate Ophthalmic Solution [Atropine-Care]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ophthalmic care personnel (including retina specialists, general ophthalmologists, nurses, and photographers) reading digital fundus images without additional training
Trial: 11288794
Drug: Alendronate (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (10 mg/daily)
Trial: 8308716
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) capsules containing 20.0 mg
Trial: 8308716
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) capsules containing 40.0 mg
Trial: 8308716
Drug: Conventional ISDN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional ISDN tablets (5.0 mg each)
Trial: 31680344
Drug: Lateral/panoramic view
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lateral/panoramic view capsule (CapsoCam Plus)
Trial: 31680344
Drug: Axial view
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Axial view capsule (PillCam SB3)
Trial: 28836993
Drug: Flucloxacillin 500
RxNorm normalized name: cloxacillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flucloxacillin 500 mg four times daily and placebo
Trial: 28836993
Drug: Flucloxacillin 500
RxNorm normalized name: cloxacillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flucloxacillin 500 mg four times daily and phenoxymethylpenicillin 500 mg four times daily
Trial: 11454883
Drug: Letrozole 2.5
RxNorm normalized name: letrozole 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole 2.5 mg daily
Trial: 16135166
Drug: Nedocromil (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nedocromil (8 mg)
Trial: 9374925
Drug: Sulphasalazine (SSZ)
RxNorm normalized name: Sulfasalazine
DrugBank: Sulfasalazine (DB00795)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulphasalazine (SSZ) 2000 mg daily (maximum 3000 mg)
Trial: 9374925
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 7.5 mg weekly (maximum 15 mg)
Trial: 9374925
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of sulphasalazine and methotrexate (COMBI)
Trial: 1525791
Drug: Cefaclor AF
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor AF (750 mg twice daily)
Trial: 1617044
Drug: Cefaclor (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor (500 mg three times daily)
Trial: 3903579
Drug: Oral ritodrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ritodrine therapy
Trial: 24636287
Drug: Entecavir (ETV)
RxNorm normalized name: Entecavir
DrugBank: Entecavir (DB00442)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Entecavir (ETV) 0.5 mg/day
Trial: 29767743
Drug: Low-fat yogurt
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat yogurt (339 g)
Trial: 29767743
Drug: Soy pudding
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy pudding (324 g)
Trial: 22607109
Drug: Latanoprost 50
RxNorm normalized name: Latanoprost 50 microgram/mL eye drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Latanoprost 50 μg/mL
Trial: 22607109
Drug: Latanoprost 75
RxNorm normalized name: Latanoprost
DrugBank: Latanoprost (DB00654)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Latanoprost 75 μg/mL
Trial: 22607109
Drug: Latanoprost 100
RxNorm normalized name: latanoprost 100 % MISCELL OIL (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Latanoprost 100 μg/mL
Trial: 22607109
Drug: Latanoprost 125
RxNorm normalized name: latanoprost 125 MCG per 2.5 ML Ophthalmic Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Latanoprost 125 μg/mL
Trial: 21121402
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (400 mcg, 6 hourly, max 4 doses)
Trial: 17407170
Drug: Oral caffeine
RxNorm normalized name: caffeine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral caffeine (480 mg) intake
Trial: 16363297
Drug: Small volume
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small volume at high concentration (5 mL of 0.75% levobupivacaine)
Trial: 16363297
Drug: Large volume
RxNorm normalized name: NEBULIZER,LARGE VOLUME #1770
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large volume at low concentration (10 mL of 0.375% levobupivacaine)
Trial: 10775784
Drug: Three-component blood-stage
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-component blood-stage malaria vaccine (recombinant proteins MSP1, MSP2, RESA with Montanide ISA720 adjuvant), injected twice (four weeks apart)
Trial: 8685289
Drug: In‐patient treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In‐patient treatment with psychoeducation for parents followed by out‐patient psychosocial intervention
Trial: 1519714
Drug: Phenytoin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenytoin (5 mg.kg‐1)
Trial: 1519714
Drug: Tubocurarine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tubocurarine (3 mg)
Trial: 6524312
Drug: Phenylephrine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine treatment
Trial: 31232721
Drug: Vaginal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal estrogen (via ring or cream)
Trial: 11461801
Drug: Investigational drug
RxNorm normalized name: INVESTIGATIONAL DRUGS FOR DEMENTIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigational drug
Trial: 18036873
Drug: Verteporfin infusion
RxNorm normalized name: Verteporfin
DrugBank: Verteporfin (DB00460)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Verteporfin infusion followed by standard light application at 15 minutes
Trial: 18036873
Drug: Verteporfin infusion
RxNorm normalized name: Verteporfin
DrugBank: Verteporfin (DB00460)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Verteporfin infusion followed by delayed light application at 30 minutes
Trial: 16282835
Drug: PAX +
RxNorm normalized name: diphenhydramine hydrochloride Topical Spray [Derma-Pax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAX + sulpiride (100 mg/d)
Trial: 16282835
Drug: PAX (10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAX (10-40 mg/d)
Trial: 7744584
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of chemotherapy and endocrine manipulation for node-negative breast cancer
Trial: 7744584
Drug: Chemoendocrine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoendocrine therapy for node-positive disease
Trial: 7744584
Drug: Delayed reintroduction
RxNorm normalized name: INTRODUCTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed reintroduction of chemotherapy after initial cytotoxic treatment for node-positive disease
Trial: 7744584
Drug: Adjuvant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant treatment for breast cancer
Trial: 31668965
Drug: Renshen Yangrong
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renshen Yangrong Tang (RSYRT) herbal extract granules, taken twice a day for six weeks.
Trial: 31668965
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (low dose of a single herb - huangqi, taken twice a day for six weeks).
Trial: 31703669
Drug: Integrated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated treatment of HCV in PWID, which includes testing for HCV, assessing liver fibrosis, counselling, treatment delivery, follow-up, and evaluation in integrated substance use disorder treatment clinics.
Trial: 31703669
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care involving referral to further diagnostics, treatment, and treatment follow-up in a hospital outpatient clinic.
Trial: 31703669
Drug: Integrated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated treatment of HCV in PWID.
Trial: 26020764
Drug: Baseline fasting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline fasting plasma glucose value increase by 1 mmol/L
Trial: 26020764
Drug: Baseline fasting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline fasting plasma glucose value increase by 1 mmol/L (after adjustment)
Trial: 24016248
Drug: Statin-benzafibrate combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin-benzafibrate combination therapy (atorvastatin 20 mg QN + bezafibrate 200 mg BID)
Trial: 24016248
Drug: Statin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin monotherapy (atorvastatin 20 mg QN or equivalent)
Trial: 24016248
Drug: Statin-benzafibrate combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin-benzafibrate combination therapy
Trial: 18596116
Drug: Amiloride (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiloride (10 mg daily for 6 weeks)
Trial: 18596116
Drug: Alternate psychotropic
RxNorm normalized name: Alternaria alternata
DrugBank: Alternaria alternata (DB10424)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate psychotropic medications (control group)
Trial: 12352887
Drug: Oral itraconazole
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral itraconazole solution (200 mg every 12 hr)
Trial: 12352887
Drug: Intravenous/oral fluconazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous/oral fluconazole (400 mg every 24 hr)
Trial: 12352887
Drug: Oral itraconazole
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral itraconazole solution
Trial: 12352887
Drug: Intravenous/oral fluconazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous/oral fluconazole
Trial: 8852867
Drug: 10-mg baclofen
RxNorm normalized name: baclofen 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-mg baclofen
Trial: 8852867
Drug: 20-mg baclofen
RxNorm normalized name: baclofen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-mg baclofen
Trial: 1839722
Drug: Chlorhexidine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine treatment (ethyl cellulose containing chlorhexidine)
Trial: 6662171
Drug: slow-release disopyramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: slow-release disopyramide phosphate (DR) 300 mg twice daily
Trial: 6662171
Drug: long-acting propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: long-acting propranolol (PR) 1 X 160 mg daily
Trial: 24552555
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care + brief ACT-based intervention (five group therapy sessions integrating educational topics on heart-healthy behaviours with acceptance and mindfulness skills)
Trial: 22136711
Drug: 8 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 g/d of fish oil (1.6 g/d EPA+DHA; n=17)
Trial: 22136711
Drug: 8 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 g/d of oxidised fish oil (1.6 g/d EPA+DHA; n=18)
Trial: 22136711
Drug: 8 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 g/d of high-oleic sunflower oil (n=19)
Trial: 22136711
Drug: Both fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both fish oil groups (8 g/d of fish oil and 8 g/d of oxidised fish oil)
Trial: 18661414
Drug: Intravenous low
RxNorm normalized name: Dianeal Low Calcium 1.5 Intraperitoneal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous low molecular weight iron dextran (ID)
Trial: 29667099
Drug: Drug discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug discontinuation
Trial: 6362699
Drug: Brotizolam 0.25
RxNorm normalized name: brotizolam 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brotizolam 0.25 mg
Trial: 10030617
Drug: Contrast sensitivity
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast sensitivity measured with sine-wave grating patches at varying luminance and eccentricity levels.
Trial: 2185299
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg glypressin intravenously (i.v.)
Trial: 7379678
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution without bile salts
Trial: 20636718
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with uric acid (1 g) and rtPA
Trial: 16645532
Drug: Cimicifuga racemosa
RxNorm normalized name: CIMICIFUGA RACEMOSA ROOT
DrugBank: Black cohosh (DB13975)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimicifuga racemosa (CR) 40 mg/day
Trial: 16645532
Drug: Conjugated estrogens
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens (CE) 0.6 mg/day
Trial: 6762167
Drug: Torasemide 60
RxNorm normalized name: torsemide 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Torasemide 60 mg
Trial: 6762167
Drug: Furosemide 120
RxNorm normalized name: furosemide 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 120 mg
Trial: 24909293
Drug: Dapagliflozin 5
RxNorm normalized name: dapagliflozin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin 5 mg and 10 mg
Trial: 23384091
Drug: Rupatadine oral
RxNorm normalized name: rupatadine
DrugBank: Rupatadine (DB11614)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Rupatadine oral solution (1 mg/ml)
Trial: 20939473
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH) 5000 U/day (high dose group)
Trial: 20939473
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH) 2500 U/day (low dose group)
Trial: 10754612
Drug: Sedative and
RxNorm normalized name: Anxiolytic, sedative AND/OR hypnotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedative and PPIA group
Trial: 10754612
Drug: Sedative group
RxNorm normalized name: MedActive Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedative group
Trial: 3908125
Drug: Piretanide 6
RxNorm normalized name: piretanide 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piretanide 6 mg once daily
Trial: 3908125
Drug: Piretanide 6
RxNorm normalized name: piretanide 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piretanide 6 mg twice daily
Trial: 3908125
Drug: Hydrochlorothiazide 50
RxNorm normalized name: hydrochlorothiazide 50 MG
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 50 mg/amiloride 5 mg twice daily (HCT/A)
Trial: 22658123
Drug: Finasteride 0.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 0.5% solution applied twice daily
Trial: 22658123
Drug: Placebo solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo solution applied twice daily
Trial: 15957830
Drug: Danshen injection
RxNorm normalized name: DANSHEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danshen injection (DSI) 60 ml once a day for 10 days
Trial: 11803077
Drug: Combined hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined hepatitis A and B vaccine (Twinrix) administered on days 0, 7, and 21
Trial: 11803077
Drug: Simultaneous administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simultaneous administration of monovalent hepatitis A and B vaccines
Trial: 17241248
Drug: Combined hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined hepatitis A and B vaccine (Twinrix)
Trial: 10429000
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (I‐NO) therapy at doses of 1, 4, and 16 ppm.
Trial: 10429000
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (I‐NO) therapy (pooled doses) for treatment failures.
Trial: 10429000
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group for treatment failures.
Trial: 25381629
Drug: Tadalafil (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil (20 mg/day)
Trial: 15736915
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (1.3 g EPA and 0.9 g DHA per day) from week 30 of gestation (FO(pregn/lact))
Trial: 15736915
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (1.3 g EPA and 0.9 g DHA per day) from week 30 of gestation (FO(pregn))
Trial: 10883412
Drug: Hydrochlorothiazide (HCTZ,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ, 12.5 mg daily)
Trial: 8472720
Drug: verapamil 120
RxNorm normalized name: verapamil 120 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil 120 mg t.i.d.
Trial: 2436462
Drug: Thrombin method
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombin method (5,000 units/5 cc. X 2)
Trial: 19934280
Drug: bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: bupropion SR combined with cognitive behavioral group therapy (CBGT) (group C)
Trial: 15257187
Drug: Perindopril (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (2 mg) and Indapamide (0.625 mg)
Trial: 9588696
Drug: Estradiol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol (100 microg by patch)
Trial: 9588696
Drug: Progesterone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progesterone (100 mg i.m.)
Trial: 8108665
Drug: Prednisolone 50
RxNorm normalized name: prednisolone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 50 mg per day for 14 days, then 25 mg per day for another 14 days.
Trial: 8108665
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets for the same time period (14 days of 50 mg, then 14 days of 25 mg).
Trial: 2697953
Drug: Laser therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser therapy using helium-neon, infrared, argon, and helium-cadmium lasers
Trial: 163938
Drug: ABOB 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABOB 1% solution applied topically
Trial: 25433580
Drug: Calcium Fructoborate
RxNorm normalized name: CALCIUM FRUCTOBORATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium Fructoborate 112 mg/day (CFB-1)
Trial: 25433580
Drug: Calcium Fructoborate
RxNorm normalized name: CALCIUM FRUCTOBORATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium Fructoborate 56 mg/day (CFB-2)
Trial: 23515980
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple therapy (pantoprazole 40 mg, clarithromycin 500 mg, and amoxicillin 1 g each administered twice daily for 10 days)
Trial: 23515980
Drug: Sequential therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential therapy (pantoprazole 40 mg plus amoxicillin 1 g twice daily for 5 days followed by pantoprazole 40 mg, clarithromycin 500 mg, and tinidazole 500 mg each administered twice daily for 5 days)
Trial: 16961694
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg day(-1) micronized progesterone
Trial: 16961694
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg day(-1) oestradiol
Trial: 16961694
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of progesterone and oestradiol
Trial: 16961694
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of hormone supplement
Trial: 11729008
Drug: Combined psychotherapy
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined psychotherapy and pharmacotherapy